Matches in SemOpenAlex for { <https://semopenalex.org/work/W2118815158> ?p ?o ?g. }
- W2118815158 endingPage "355" @default.
- W2118815158 startingPage "343" @default.
- W2118815158 abstract "It has been reported that N-methyl-d-aspartate (NMDA) receptor is implicated in drug addiction and antagonists of the NMDA receptor complex can inhibit the development and expression of conditioned place preference (CPP) induced by several addictive drugs, implying that this class of compounds might be considered as candidate for the treatment of substance abuse. To explore this possibility, it is important to evaluate whether the inhibitory effect of NMDA receptor antagonists would be confined to behaviors produced by drugs of abuse only, but not by natural reinforcers. According to the quantitative changes of NMDA receptor subunits, including NR1, NR2A, and NR2B, induced by diverse types of reinforcers, we chose NR2B subunit as the target of research. Experimental results showed that (1) an augmented expression of NR2B subunit was revealed by Western blotting in the nucleus accumbens (NAc) and the hippocampus in rats with CPP induced by morphine, but not by natural rewards such as food, novel environment and social interaction. (2) Ifenprodil, an antagonist highly selective for NR2B subunit of the NMDA receptor, produced a dose-dependent reduction in CPP induced by morphine and novel environment, but not that by food consumption and social interaction. Taking together, these findings suggested that NR2B containing NMDA receptor may be more involved with morphine reward rather than natural rewards, and that antagonism of NR2B may have a potential for the treatment of morphine abuse." @default.
- W2118815158 created "2016-06-24" @default.
- W2118815158 creator A5023069485 @default.
- W2118815158 creator A5051175105 @default.
- W2118815158 creator A5058283645 @default.
- W2118815158 creator A5081559905 @default.
- W2118815158 creator A5087607230 @default.
- W2118815158 creator A5088248875 @default.
- W2118815158 date "2006-08-01" @default.
- W2118815158 modified "2023-10-11" @default.
- W2118815158 title "The role of NR2B containing NMDA receptor in place preference conditioned with morphine and natural reinforcers in rats" @default.
- W2118815158 cites W121409461 @default.
- W2118815158 cites W1526412808 @default.
- W2118815158 cites W1964127562 @default.
- W2118815158 cites W1966129244 @default.
- W2118815158 cites W1970409387 @default.
- W2118815158 cites W1971289794 @default.
- W2118815158 cites W1972345009 @default.
- W2118815158 cites W1976403478 @default.
- W2118815158 cites W1978945264 @default.
- W2118815158 cites W1983038420 @default.
- W2118815158 cites W1989505370 @default.
- W2118815158 cites W1990720634 @default.
- W2118815158 cites W1991515600 @default.
- W2118815158 cites W1996244586 @default.
- W2118815158 cites W2000853777 @default.
- W2118815158 cites W2001189298 @default.
- W2118815158 cites W2003230152 @default.
- W2118815158 cites W2003301993 @default.
- W2118815158 cites W2003432290 @default.
- W2118815158 cites W2006191211 @default.
- W2118815158 cites W2008605050 @default.
- W2118815158 cites W2013851440 @default.
- W2118815158 cites W2020191830 @default.
- W2118815158 cites W2023504580 @default.
- W2118815158 cites W2026219855 @default.
- W2118815158 cites W2026776441 @default.
- W2118815158 cites W2027775550 @default.
- W2118815158 cites W2028594041 @default.
- W2118815158 cites W2035070639 @default.
- W2118815158 cites W2041247261 @default.
- W2118815158 cites W2043911241 @default.
- W2118815158 cites W2046020934 @default.
- W2118815158 cites W2047753893 @default.
- W2118815158 cites W2049796382 @default.
- W2118815158 cites W2052205730 @default.
- W2118815158 cites W2054090721 @default.
- W2118815158 cites W2055018246 @default.
- W2118815158 cites W2055319462 @default.
- W2118815158 cites W2055969312 @default.
- W2118815158 cites W2056477716 @default.
- W2118815158 cites W2057657658 @default.
- W2118815158 cites W2059401172 @default.
- W2118815158 cites W2061344417 @default.
- W2118815158 cites W2062123657 @default.
- W2118815158 cites W2073618643 @default.
- W2118815158 cites W2073782853 @default.
- W2118815158 cites W2079615996 @default.
- W2118815158 cites W2081041064 @default.
- W2118815158 cites W2083832493 @default.
- W2118815158 cites W2086087006 @default.
- W2118815158 cites W2087336696 @default.
- W2118815158 cites W2088797349 @default.
- W2118815158 cites W2088891858 @default.
- W2118815158 cites W2089152452 @default.
- W2118815158 cites W2094038059 @default.
- W2118815158 cites W2096397785 @default.
- W2118815158 cites W2100212375 @default.
- W2118815158 cites W2117745130 @default.
- W2118815158 cites W2120411894 @default.
- W2118815158 cites W2124405898 @default.
- W2118815158 cites W2134753588 @default.
- W2118815158 cites W2135720249 @default.
- W2118815158 cites W2136911105 @default.
- W2118815158 cites W2144724143 @default.
- W2118815158 cites W2147390337 @default.
- W2118815158 cites W2150010745 @default.
- W2118815158 cites W2150828391 @default.
- W2118815158 cites W2162346026 @default.
- W2118815158 cites W2169992401 @default.
- W2118815158 cites W2171521575 @default.
- W2118815158 cites W2328931461 @default.
- W2118815158 cites W4255221990 @default.
- W2118815158 cites W2072884119 @default.
- W2118815158 doi "https://doi.org/10.1016/j.expneurol.2006.02.117" @default.
- W2118815158 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16631172" @default.
- W2118815158 hasPublicationYear "2006" @default.
- W2118815158 type Work @default.
- W2118815158 sameAs 2118815158 @default.
- W2118815158 citedByCount "80" @default.
- W2118815158 countsByYear W21188151582012 @default.
- W2118815158 countsByYear W21188151582013 @default.
- W2118815158 countsByYear W21188151582014 @default.
- W2118815158 countsByYear W21188151582015 @default.
- W2118815158 countsByYear W21188151582016 @default.
- W2118815158 countsByYear W21188151582017 @default.
- W2118815158 countsByYear W21188151582018 @default.
- W2118815158 countsByYear W21188151582019 @default.